Skip to main content
WeightCited

Chromium 관련 인슐린 저항성

B 근거 적어도 하나의 무작위 시험이 이를 지지하며, 대체로 일관된 결과를 보입니다.

Meta-analysis of 25 RCTs found significant improvements in fasting glucose (1.16 mmol/L) in type 2 diabetics. Chromium enhances insulin receptor substrate phosphorylation. The ADA notes insufficient evidence for routine recommendation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dchromium\u0026condition\u003Dinsulin\u002Dresistance'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

결론

Meta-analysis of 25 RCTs found significant improvements in fasting glucose (1.16 mmol/L) in type 2 diabetics. Chromium enhances insulin receptor substrate phosphorylation. The ADA notes insufficient evidence for routine recommendation.

Key Study Findings

Meta-Analysis
Comparative effects of vitamin and mineral supplements in the management of type 2 diabetes in …
Dose: Various vitamins and minerals vs: Placebo or standard care Outcome: Glycemic control and lipid metabolism 효과: None None

대상 집단: T2DM patients in primary care (RCTs)

Review
Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS.
Dose: None vs: None Outcome: Menstrual cycle regulation 효과: None None

대상 집단: Adolescents with PCOS

Controlled Clinical Trial n=77
Hypoglycemic and Hypolipidemic Effects of Leucine, Zinc, and Chromium, Alone and in Combination, in Rats …
Dose: leucine, zinc, and chromium alone/combined vs: vehicle-treated T2D rats Outcome: blood glucose and serum lipid profile 효과: None <0.05

대상 집단: Male Wistar rats with type 2 diabetes

Key Statistics

25

연구

2000

참여자

Positive

B

등급

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
25-35 mcg/day (AI)
weightmanagement:
200-1,000 mcg/day chromium picolinate
insulinsensitivity:
500-1,000 mcg/day

상한량: No established UL; long-term safety data at >1,000 mcg/day limited

연구에서 사용된 용량

용량 기간 효과 N
Various vitamins and minerals -- Positive --
None -- Positive --
leucine, zinc, and chromium alone/combined -- Positive 77

권장 복용 시간: With meals

Safety & Side Effects

보고된 부작용

  • Headache
  • Insomnia
  • Mood changes
  • GI discomfort

알려진 상호작용

  • Diabetes medications (may potentiate — hypoglycemia risk)
  • Insulin
  • Sulfonylureas
  • Levothyroxine (reduced absorption)

일일 최대 섭취 허용량: No established UL; long-term safety data at >1,000 mcg/day limited

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Chromium help with 인슐린 저항성?
Based on 25 studies with 2,000 participants, there is moderate evidence from clinical studies that Chromium may support 인슐린 저항성 management. Our evidence grade is B (Good Evidence).
How much Chromium should I take for 인슐린 저항성?
Studies have used various dosages. A commonly studied range is 25-35 mcg/day (AI). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Chromium?
Reported side effects may include Headache, Insomnia, Mood changes, GI discomfort. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Chromium and 인슐린 저항성?
We rate the evidence as Grade B (Good Evidence). This rating is based on 25 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

References

  1. [1] Jiayue Xia et al.. Pharmacol Res. 2023. Comparative effects of vitamin and mineral supplements in the management of type 2 diabetes in primary care: A systematic review … doi:10.1016/j.phrs.2023.106647 PubMed
  2. [2] Elisabeth Reiser et al.. J Clin Med. 2022. Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS. doi:10.3390/jcm12010067 PubMed
  3. [3] Hassan Sadri et al.. Biol Trace Elem Res. 2017. Hypoglycemic and Hypolipidemic Effects of Leucine, Zinc, and Chromium, Alone and in Combination, in Rats with Type 2 Diabetes. doi:10.1007/s12011-017-1014-2 PubMed

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.